1. Home
  2. EWTX vs VITL Comparison

EWTX vs VITL Comparison

Compare EWTX & VITL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EWTX
  • VITL
  • Stock Information
  • Founded
  • EWTX 2017
  • VITL 2007
  • Country
  • EWTX United States
  • VITL United States
  • Employees
  • EWTX N/A
  • VITL N/A
  • Industry
  • EWTX Biotechnology: Pharmaceutical Preparations
  • VITL Packaged Foods
  • Sector
  • EWTX Health Care
  • VITL Consumer Staples
  • Exchange
  • EWTX Nasdaq
  • VITL Nasdaq
  • Market Cap
  • EWTX 1.5B
  • VITL 1.6B
  • IPO Year
  • EWTX 2021
  • VITL 2020
  • Fundamental
  • Price
  • EWTX $13.93
  • VITL $47.70
  • Analyst Decision
  • EWTX Buy
  • VITL Strong Buy
  • Analyst Count
  • EWTX 8
  • VITL 9
  • Target Price
  • EWTX $41.13
  • VITL $46.89
  • AVG Volume (30 Days)
  • EWTX 633.0K
  • VITL 1.1M
  • Earning Date
  • EWTX 08-07-2025
  • VITL 08-07-2025
  • Dividend Yield
  • EWTX N/A
  • VITL N/A
  • EPS Growth
  • EWTX N/A
  • VITL 5.37
  • EPS
  • EWTX N/A
  • VITL 1.13
  • Revenue
  • EWTX N/A
  • VITL $657,947,000.00
  • Revenue This Year
  • EWTX N/A
  • VITL $25.34
  • Revenue Next Year
  • EWTX N/A
  • VITL $19.58
  • P/E Ratio
  • EWTX N/A
  • VITL $42.44
  • Revenue Growth
  • EWTX N/A
  • VITL 21.49
  • 52 Week Low
  • EWTX $10.60
  • VITL $27.91
  • 52 Week High
  • EWTX $38.12
  • VITL $48.26
  • Technical
  • Relative Strength Index (RSI)
  • EWTX 52.63
  • VITL 74.62
  • Support Level
  • EWTX $12.30
  • VITL $35.40
  • Resistance Level
  • EWTX $14.11
  • VITL $47.85
  • Average True Range (ATR)
  • EWTX 0.73
  • VITL 1.91
  • MACD
  • EWTX 0.00
  • VITL 1.09
  • Stochastic Oscillator
  • EWTX 53.80
  • VITL 94.21

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

About VITL Vital Farms Inc.

Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).

Share on Social Networks: